Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial

BACKGROUND: Currently, there are no established pharmacotherapies for cannabis use disorders (CUDs). As a long-acting alpha-2-adrenergic receptor agonist, guanfacine extended-release (G-XR) could be useful in the treatment of CUDs by mitigating withdrawal and improving behavioral control. OBJECTIVES...

Full description

Saved in:
Bibliographic Details
Published in:Am J Drug Alcohol Abuse
Main Authors: Dakwar, Elias, Mahony, Amy, Choi, C. Jean, Pavlicova, Martina, Brooks, Daniel, Mariani, John P., Levin, Frances R.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6949416/
https://ncbi.nlm.nih.gov/pubmed/31339797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2019.1620259
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items